Assessing the Contribution Family Data Can Make to Case‐Control Studies of Rare Variants

Centre for Psychiatry, Barts and The London School of Medicine and Dentistry, London, UK.
Annals of Human Genetics (Impact Factor: 2.21). 06/2011; 75(5):630-8. DOI: 10.1111/j.1469-1809.2011.00660.x
Source: PubMed

ABSTRACT When pathogenic variants are rare then even among cases the proportion of subjects possessing a variant might be low, meaning that very large samples might be required to conclusively demonstrate evidence of an effect. Relatives of subjects within a case-control sample might provide useful additional information.
The method of model-free linkage analysis implemented in MFLINK was adapted to incorporate linkage disequilibrium (LD) parameters in order to test for an effect of a putative pathogenic variant in complete LD with a disease locus. The effect of adding in to the analysis relatives of cases and controls found to carry the variant was investigated.
When affected siblings or cousins of cases possessing the variant were incorporated they had a large effect on the results obtained. The evidence for involvement increased or reduced as expected, depending on whether or not the relatives themselves were found to possess the variant. The size of the effect was large relative to that expected from just increasing the size of a standard case-control sample.
Affected relatives offer a valuable resource to assist the interpretation of case-control studies of rare variants. The method is capable of including other relative types and can deal with complex pedigrees.

Download full-text


Available from: David Curtis, Jun 16, 2015
11 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The results of linkage and association studies imply that there are no common, dominantly active variants which have a substantial effect on the risk of schizophrenia. However, there are rare structural variants with a major effect and it is argued that results to date are not incompatible with the existence of large numbers of individually rare sequence variants with major effect, since these would not have been detected by the methods used to date. It is also argued that the epidemiology is consistent with a contribution from recessively acting variants and that likewise these might have gone undetected. It is shown that methods of analysis specifically designed to detect recessive variants through testing departure from Hardy-Weinberg equilibrium offer substantial increases of power over conventional methods. It is recommended that analytic approaches aim to detect very rare variants with major effect and that specific attempts are made to detect recessively acting loci.
    Psychiatric genetics 02/2013; 23(1):1-10. DOI:10.1097/YPG.0b013e32835d7e5a · 1.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Familial aggregation of fibromyalgia has been increasingly recognized. The goal of this study was to conduct a genome-wide linkage scan to identify susceptibility loci for fibromyalgia. Methods: We genotyped members of 116 families from the Fibromyalgia Family Study and performed a model-free genome-wide linkage analysis of fibromyalgia with 341 microsatellite markers, using the Haseman-Elston regression approach. Results: The estimated sibling recurrence risk ratio (λs ) for fibromyalgia was 13.6 (95% confidence interval 10.0-18.5), based on a reported population prevalence of 2%. Genome-wide suggestive evidence of linkage was observed at markers D17S2196 (empirical P [Pe ]=0.00030) and D17S1294 (Pe=0.00035) on chromosome 17p11.2-q11.2. Conclusion: The estimated sibling recurrence risk ratio (λs ) observed in this study suggests a strong genetic component of fibromyalgia. This is the first report of genome-wide suggestive linkage of fibromyalgia to the chromosome 17p11.2-q11.2 region. Further investigation of these multicase families from the Fibromyalgia Family Study is warranted to identify potential causal risk variants for fibromyalgia.
    Arthritis & Rheumatology 04/2013; 65(4). DOI:10.1002/art.37842 · 7.76 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Family data represent a rich resource for detecting association between rare variants (RVs) and human traits. However, most RV association analysis methods developed in recent years are data-driven burden tests which can adaptively learn weights from data but require permutation to evaluate significance, thus are not readily applicable to family data, because random permutation will destroy family structure. Direct application of these methods to family data may result in a significant inflation of false positives. To overcome this issue, we have developed a generalized, weighted sum mixed model (WSMM), and corresponding computational techniques that can incorporate family information into data-driven burden tests, and allow adaptive and efficient permutation test in family data. Using simulated and real datasets, we demonstrate that the WSMM method can be used to appropriately adjust for genetic relatedness among family members and has a good control for the inflation of false positives. We compare WSMM with a nondata-driven, family-based Sequence Kernel Association Test (famSKAT), showing that WSMM has significantly higher power in some cases. WSMM provides a generalized, flexible framework for adapting different data-driven burden tests to analyze data with any family structures, and it can be extended to binary and time-to-onset traits, with or without covariates.
    Genetic Epidemiology 12/2014; 38(8). DOI:10.1002/gepi.21848 · 2.60 Impact Factor